An observational study of inflammation in the central nervous system in patients with bipolar disorder.


The potential influence of infections andimmunological changes on the aetiology and pathogenesis of bipolar disorder (BD) has been discussed. Our aim was to detect intrathecal specific antibody synthesis against the neurotropic infectious agents that have previously been linked to BD.


Paired cerebrospinal fluid (CSF) and serum samples from 40 patients with BD
were analysed using the enzyme-linked immunosorbent assay to detect the
concentration of antibodies against the following neurotropic infectious
pathogens: Toxoplasma gondii (T. gondii), herpes simplex virus (HSV)
types 1 and 2, cytomegalovirus (CMV), and Epstein-Barr virus (EBV). The
specific antibody index (AI) was calculated, and an AI > 1.4 was
considered to be evidence of intrathecal specific antibody synthesis.
Twenty-six patients with pseudotumour cerebri served as controls.


Eight out of 40 patients with BD displayed specific intrathecal antibody synthesis against at least one of the tested neurotropic agents compared to only one patient in the control group (p = 0.061, not significant) . Of these eight patients with BD, no significant prevalence of any particular neurotropic pathogen was evident. Five out of 40 patients with BD showed oligoclonal bands in the CSF, suggestive of a chronic immune reaction in the central nervous system (CNS).


We found evidence for increased production of antibody in the CSF of individuals with BD. However, the trend for polyspecific intrathecal antibody synthesis, as well as the presence of oligoclonal bands, might indicate activation of the intrathecal humoral immune system in a subgroup of patients with BD, as it is known to be associated with autoimmune disorders of the CNS.

No comments: